Xynomic Pharmaceuticals' Reverse Merger Round

Xynomic Pharmaceuticals raised a round of funding on September 13, 2018. Investors include Bison Capital Acquisition Corp..

Xynomic Pharmaceuticals (徐诺药业) is a biopharmaceutical company focusing on in-licensing, developing, and commercializing oncology drug candidates.…

Articles about Xynomic Pharmaceuticals' Reverse Merger Round: